Cara Therapeutics Inc. sell StockNews.com
Start price
02.09.24
/
50%
€0.31
Target price
02.09.25
-
Performance (%)
11.73%
End price
03.09.25
-
Summary
This prediction is currently being closed. The prediction currently has a disappointing performance of 11.73%. StockNews_com has a follow-up prediction for Cara Therapeutics Inc. where he still thinks Cara Therapeutics Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cara Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.245% | -2.945% | 26.279% |
| iShares Nasdaq 100 | 1.694% | 0.358% | 16.932% |
| iShares Nikkei 225® | 3.771% | 3.520% | 10.311% |
| iShares S&P 500 | 1.432% | 1.130% | 11.638% |
Comments by StockNews_com for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CARA provided by MarketBeat
In the thread Trading Cara Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Cara Therapeutics Inc.
Stopped prediction by StockNews_com for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
17.02.24
17.02.24
-
17.02.25
17.02.25
-25.51%
18.02.25
18.02.25
